Introduction: Madhumeha is a Vataja type of Tridoshaja disease. Vanga is used
abundantly in practice of Ayurveda for the treatment of Madhumeha. It is a drug of choice for the
management of Madhumeha (DM-II). Guduchi Ghana ( aqueous extract of Tinospora cordifolia
(Willd.) Miers) of is also having Mehahara effect and old honey is also to be claimed for Mehaghna
properties. Material and methods: In present study total 64 patients were registered. Out of them
in Group A total 32 patients were managed with Vanga Bhasma (250 mg) along with Guduchi
Ghana (250 mg) + Old Honey (3 ml) as Sahapana whereas in Group B, 32 patients were managed
with Guduchi Ghana (250 mg) + Old Honey (3 ml) for 28 days. Observations and Results: Present
study 14%, 28% and 10% of patients markedly improvement, moderate improvement, mildly
improvement were found in Group A respectively. While 2%, 10% and 24% markedly improvement,
moderate improvement, and mildly improvement were found in Group B respectively. Overall
result showed that Vanga Bhasma possesses the antihyperglycemic effect along with its Sahapana
and it doesn’t have hypoglycemic effect. Conclusion: Vanga Bhasma with Sahapana (Guduchi
Ghana) was found moderate anti-hyperglycemic agent in the patients of Madhumeha (Type-2
yurvedic treatment; Diabetes mellitus; Guduchi Ghana; Madhumeha; Madhu;
Honey; Vanga Bhasma.
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?
Taylor A, Bejarano E
Neural regeneration research. 2022; 17(2): 320-322
Exosome treatment for stroke with diabetic comorbidity.
Venkat P, Chopp M
Neural regeneration research. 2022; 17(2): 315-317
Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299
Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.
Flack JA, Sharma KD, Xie JY
Neural regeneration research. 2022; 17(2): 283-291
Potential use of lactate for the treatment of neonatal hypoxic-ischemic encephalopathy.
Tassinari ID, de Fraga LS
Neural regeneration research. 2022; 17(4): 788-790